We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
414 hedge funds and large institutions have $24B invested in Regeneron Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 169 increasing their positions, 124 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
132% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 34
44% more funds holding in top 10
Funds holding in top 10: 9 → 13 (+4)
41% more capital invested
Capital invested by funds: $17B → $24B (+$7B)
36% more repeat investments, than reductions
Existing positions increased: 169 | Existing positions reduced: 124
12% more funds holding
Funds holding: 371 → 414 (+43)
3% less call options, than puts
Call options by funds: $388M | Put options by funds: $401M
Holders
414
Holders Change
+43
Holders Change %
+11.59%
% of All Funds
13.42%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.42%
New
79
Increased
169
Reduced
124
Closed
34
Calls
$388M
Puts
$401M
Net Calls
-$12.3M
Net Calls Change
-$49.4M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$354M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$153M |
| 3 |
JP Morgan Chase
New York
|
-$87.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$86.8M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$63.4M |
